Factors Contributing to the Potency of CD8 T Cells

Overview

Journal Trends Immunol

Specialty Allergy & Immunology

Date 2023 Aug 9

PMID 37558570

Authors

Yuri Sykulev

Affiliations

Soon will be listed here.

Abstract

CD8 cytotoxic T lymphocytes (CTLs) play a crucial role in targeting virus-infected and cancer cells. Although other cytotoxic lymphocytes such as CD4 T and natural killer (NK) cells, as well as chimeric antigen receptor (CAR)-T cells, can also identify and destroy aberrant cells, they seem to be significantly less potent based on available experimental data. Here, I contemplate the molecular mechanisms controlling the sensitivity and kinetics of granule-mediated CD8 T cell cytolytic responses. I posit that the clustering of MHC-I molecules and T cell receptors (TCRs) on the cell surface, as well as the contribution of the CD8 co-receptor, are major factors driving exceptionally potent cytolytic responses. I also contend that CD8 T cells with known specificity and engineered TCR-T cells might be among the most efficient cytolytic effectors for treating patients suffering from viral infections or cancer.

Citing Articles

MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy.

Deshpande R, Wu K, Wu S, Tyagi A, Smith E, Kim J EMBO Mol Med. 2025; .

PMID: 40087501 DOI: 10.1038/s44321-025-00213-7.

Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies.

Wang H, Zhou F, Qin W, Yang Y, Li X, Liu R Theranostics. 2025; 15(6):2159-2184.

PMID: 39990210 PMC: 11840731. DOI: 10.7150/thno.105276.

Bioinformatics-based analysis of the role of immune-related genes in acute rejection after kidney transplantation and renal cancer development.

Huang S, Yin H Medicine (Baltimore). 2025; 103(47):e40270.

PMID: 39809189 PMC: 11596506. DOI: 10.1097/MD.0000000000040270.

The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.

Ahuja S, Zaheer S Korean J Clin Oncol. 2025; 20(2):51-73.

PMID: 39778508 PMC: 11717579. DOI: 10.14216/kjco.24009.

Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives.

Ye Z, Cheng P, Huang Q, Hu J, Huang L, Hu G Front Immunol. 2024; 15:1388176.

PMID: 38840908 PMC: 11150710. DOI: 10.3389/fimmu.2024.1388176.

References

Anikeeva N, Panteleev S, Mazzanti N, Mizue Terai , Sato T, Sykulev Y . Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs. J Biol Chem. 2021; 297(3):101033. PMC: 8452787. DOI: 10.1016/j.jbc.2021.101033. View

Pasternack M, Eisen H . A novel serine esterase expressed by cytotoxic T lymphocytes. Nature. 1985; 314(6013):743-5. DOI: 10.1038/314743a0. View

Rosenberg J, Huang J . CD8 T Cells and NK Cells: Parallel and Complementary Soldiers of Immunotherapy. Curr Opin Chem Eng. 2018; 19:9-20. PMC: 5880541. DOI: 10.1016/j.coche.2017.11.006. View

Stinchcombe J, Majorovits E, Bossi G, Fuller S, Griffiths G . Centrosome polarization delivers secretory granules to the immunological synapse. Nature. 2006; 443(7110):462-5. DOI: 10.1038/nature05071. View

Walker B . Elite control of HIV Infection: implications for vaccines and treatment. Top HIV Med. 2007; 15(4):134-6. View

Rak G, Mace E, Banerjee P, Svitkina T, Orange J . Natural killer cell lytic granule secretion occurs through a pervasive actin network at the immune synapse. PLoS Biol. 2011; 9(9):e1001151. PMC: 3172191. DOI: 10.1371/journal.pbio.1001151. View

Anikeeva N, Fischer N, Blanchette C, Sykulev Y . Extent of MHC Clustering Regulates Selectivity and Effectiveness of T Cell Responses. J Immunol. 2018; 202(2):591-597. PMC: 6362847. DOI: 10.4049/jimmunol.1801196. View

Sykulev Y . T cell receptor signaling kinetics takes the stage. Sci Signal. 2010; 3(153):pe50. PMC: 3040109. DOI: 10.1126/scisignal.3153pe50. View

Ribeiro M, McNamara J . Calcium movements during pigment aggregation in freshwater shrimp chromatophores. Pigment Cell Res. 2007; 20(1):70-7. DOI: 10.1111/j.1600-0749.2006.00347.x. View

10.

Bousso P, Robey E . Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat Immunol. 2003; 4(6):579-85. DOI: 10.1038/ni928. View

11.

Sykulev Y, Cohen R, Eisen H . The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes. Proc Natl Acad Sci U S A. 1995; 92(26):11990-2. PMC: 40281. DOI: 10.1073/pnas.92.26.11990. View

12.

Huse M, Quann E, Davis M . Shouts, whispers and the kiss of death: directional secretion in T cells. Nat Immunol. 2008; 9(10):1105-11. PMC: 2905669. DOI: 10.1038/ni.f.215. View

13.

Gorga J, Horejsi V, Johnson D, Raghupathy R, Strominger J . Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J Biol Chem. 1987; 262(33):16087-94. View

14.

Huse M, Klein L, Girvin A, Faraj J, Li Q, Kuhns M . Spatial and temporal dynamics of T cell receptor signaling with a photoactivatable agonist. Immunity. 2007; 27(1):76-88. DOI: 10.1016/j.immuni.2007.05.017. View

15.

Xiong Y, Kern P, Chang H, Reinherz E . T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4. J Biol Chem. 2000; 276(8):5659-67. DOI: 10.1074/jbc.M009580200. View

16.

Anikeeva N, Lebedeva T, Clapp A, Goldman E, Dustin M, Mattoussi H . Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response. Proc Natl Acad Sci U S A. 2006; 103(45):16846-51. PMC: 1636542. DOI: 10.1073/pnas.0607771103. View

17.

Harding C, UNANUE E . Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature. 1990; 346(6284):574-6. DOI: 10.1038/346574a0. View

18.

Schober K, Muller T, Gokmen F, Grassmann S, Effenberger M, Poltorak M . Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function. Nat Biomed Eng. 2019; 3(12):974-984. DOI: 10.1038/s41551-019-0409-0. View

19.

Anikeeva N, Gakamsky D, Scholler J, Sykulev Y . Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling. PLoS One. 2012; 7(8):e41466. PMC: 3411518. DOI: 10.1371/journal.pone.0041466. View

20.

Zhong L, Zeng G, Lu X, Wang R, Gong G, Yan L . NSOM/QD-based direct visualization of CD3-induced and CD28-enhanced nanospatial coclustering of TCR and coreceptor in nanodomains in T cell activation. PLoS One. 2009; 4(6):e5945. PMC: 2693923. DOI: 10.1371/journal.pone.0005945. View